Perverse Incentives in the Medicare Prescription Drug Benefit

David McAdams, Michael Schwarz

NBER Working Paper No. 12008
Issued in February 2006
NBER Program(s):   HC   PE

We analyze some of the perverse incentives that may arise under the current Medicare prescription drug benefit design. In particular, risk adjustment for a stand-alone prescription drug benefit creates perverse incentives for prescription drug plans' coverage decisions and/or pharmaceutical companies' pricing decisions. This problem is new in that it does not arise with risk adjustment for other types of health care coverage. For this and other reasons, Medicare's drug benefit requires especially close regulatory oversight, now and in the future. We also consider a relatively minor change in how the benefit is financed that could lead to significant changes in how it functions. In particular, if all plans were required to charge the same premium, there would be less diversity in quality but also less budgetary uncertainty and less upward pressure on drug prices.

download in pdf format
   (200 K)

email paper

A non-technical summary of this paper is available in the NBER Bulletin on Aging and Health. You can sign up to receive the NBER Bulletin on Aging and Health by email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w12008

Published: McAdams, David and Michael Schwarz. "Perverse Incentives in the Medicare Prescription Drug Benefit." Inquiry 44, 2 (Summer 2007): 157-66.

Users who downloaded this paper also downloaded* these:
Kelly and Markowitz w13113 Incentives in Obesity and Health Insurance
Ruhm w12102 A Healthy Economy Can Break Your Heart
Bitler and Hoynes w12642 Welfare Reform and Indirect Impacts on Health
Kenkel, Lillard, and Mathios w11990 The Roles of High School Completion and GED Receipt in Smoking and Obesity
Kaestner and Khan w16011 Medicare Part D and its Effect on the Use of Prescription Drugs, Use of Other Health Care Services and Health of the Elderly
NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us